We explored this concept by repurposing TCR, CD25, and PD1, three major players of the T cell activation pathway, to enable CAR T cells to secrete the pro-inflammatory cytokine IL-12P70 in a tumor cell-dependent manner. Here, IL2RA is linked to neoplasm.